Obesity drugmaker Novo Nordisk raises outlook

Reuters | London | Updated: 02-05-2024 11:04 IST | Created: 02-05-2024 11:04 IST
Obesity drugmaker Novo Nordisk raises outlook
  • Country:
  • United Kingdom

Novo Nordisk raised its 2024 outlook on Thursday as the Danish drugmaker races to boost output of its hugely popular weight-loss drug Wegovy and fend off competition from Eli Lilly.

TRENDING

1
The Hidden Gatekeepers of China–Africa Trade: Standards, Quality and Compliance
Blog

The Hidden Gatekeepers of China–Africa Trade: Standards, Quality and Complia...

Global
2
Second judge blocks Trump's $100,000 fee for new H-1B worker visas

Second judge blocks Trump's $100,000 fee for new H-1B worker visas

Global
3
US Supreme Court sides with Tennessee to allow its first execution of a woman in 200 years

US Supreme Court sides with Tennessee to allow its first execution of a woma...

Global
4
Chile proposes public spending increase to jumpstart economy

Chile proposes public spending increase to jumpstart economy

Global

PERSPECTIVES AND INSIGHTS

How Governments Can Turn AI Rules Into Operational Governance

Kazakhstan’s Regional Divide Shows Why Poverty and Inequality Need Different Fixes

The Hidden Gatekeepers of China–Africa Trade: Standards, Quality and Compliance

Can Digital Systems Fix Ethiopia’s Fragmented Road Management System?

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.

Subscribe to our Newsletter  

STANDARDS & POLICIES

EDITIONS

OTHER LINKS

CONNECT

Devdiscourse
Disclaimer | Terms of use | Privacy Policy

© Copyright 2026